Dihydrolenperone is a compound with in vitro activity against non-small cell lung cancer. References: Johnson BE, Parker R, Tsai CM, Baltz J, Miller MJ, Shoemaker R, Phelps R, Bastian A, Stocker J, Phares J, et al. Phase I trial of dihydrolenperone in lung cancer patients: a novel compound with in vitro activity against lung cancer. Invest New Drugs. 1993 Feb;11(1):29-37. PubMed PMID: 8349433.

纯度：≥98%

CAS：38077-12-2